1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Exenatide 1.2.3 Liraglutide 1.2.4 Lixisenatide 1.2.5 Albiglutide 1.2.6 Others 1.3 Market by Application 1.3.1 Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Solid Tumors 1.3.3 Blood-related Tumors 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Glucagon-like Peptide-1 Receptor Agonist Market Perspective (2016-2027) 2.2 Glucagon-like Peptide-1 Receptor Agonist Growth Trends by Regions 2.2.1 Glucagon-like Peptide-1 Receptor Agonist Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Glucagon-like Peptide-1 Receptor Agonist Historic Market Share by Regions (2016-2021) 2.2.3 Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Regions (2022-2027) 2.3 Glucagon-like Peptide-1 Receptor Agonist Industry Dynamic 2.3.1 Glucagon-like Peptide-1 Receptor Agonist Market Trends 2.3.2 Glucagon-like Peptide-1 Receptor Agonist Market Drivers 2.3.3 Glucagon-like Peptide-1 Receptor Agonist Market Challenges 2.3.4 Glucagon-like Peptide-1 Receptor Agonist Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Glucagon-like Peptide-1 Receptor Agonist Players by Revenue 3.1.1 Global Top Glucagon-like Peptide-1 Receptor Agonist Players by Revenue (2016-2021) 3.1.2 Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Players (2016-2021) 3.2 Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Glucagon-like Peptide-1 Receptor Agonist Revenue 3.4 Global Glucagon-like Peptide-1 Receptor Agonist Market Concentration Ratio 3.4.1 Global Glucagon-like Peptide-1 Receptor Agonist Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Glucagon-like Peptide-1 Receptor Agonist Revenue in 2020 3.5 Glucagon-like Peptide-1 Receptor Agonist Key Players Head office and Area Served 3.6 Key Players Glucagon-like Peptide-1 Receptor Agonist Product Solution and Service 3.7 Date of Enter into Glucagon-like Peptide-1 Receptor Agonist Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Glucagon-like Peptide-1 Receptor Agonist Breakdown Data by Type 4.1 Global Glucagon-like Peptide-1 Receptor Agonist Historic Market Size by Type (2016-2021) 4.2 Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Type (2022-2027) 5 Glucagon-like Peptide-1 Receptor Agonist Breakdown Data by Application 5.1 Global Glucagon-like Peptide-1 Receptor Agonist Historic Market Size by Application (2016-2021) 5.2 Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Glucagon-like Peptide-1 Receptor Agonist Market Size (2016-2027) 6.2 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type 6.2.1 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) 6.2.2 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) 6.2.3 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2027) 6.3 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application 6.3.1 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) 6.3.2 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) 6.3.3 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2027) 6.4 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country 6.4.1 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021) 6.4.2 North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size (2016-2027) 7.2 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type 7.2.1 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) 7.2.2 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) 7.2.3 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2027) 7.3 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application 7.3.1 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) 7.3.2 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) 7.3.3 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2027) 7.4 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country 7.4.1 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021) 7.4.2 Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size (2016-2027) 8.2 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Type 8.2.1 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2027) 8.3 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Application 8.3.1 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2027) 8.4 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Region 8.4.1 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size (2016-2027) 9.2 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type 9.2.1 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) 9.2.2 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) 9.2.3 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2027) 9.3 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application 9.3.1 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) 9.3.2 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) 9.3.3 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2027) 9.4 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country 9.4.1 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021) 9.4.2 Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size (2016-2027) 10.2 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Type 10.2.1 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2027) 10.3 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Application 10.3.1 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2027) 10.4 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Country 10.4.1 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GSK 11.1.1 GSK Company Details 11.1.2 GSK Business Overview 11.1.3 GSK Glucagon-like Peptide-1 Receptor Agonist Introduction 11.1.4 GSK Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) 11.1.5 GSK Recent Development 11.2 Novo Nordisk 11.2.1 Novo Nordisk Company Details 11.2.2 Novo Nordisk Business Overview 11.2.3 Novo Nordisk Glucagon-like Peptide-1 Receptor Agonist Introduction 11.2.4 Novo Nordisk Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) 11.2.5 Novo Nordisk Recent Development 11.3 Lily 11.3.1 Lily Company Details 11.3.2 Lily Business Overview 11.3.3 Lily Glucagon-like Peptide-1 Receptor Agonist Introduction 11.3.4 Lily Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) 11.3.5 Lily Recent Development 11.4 Haosoh 11.4.1 Haosoh Company Details 11.4.2 Haosoh Business Overview 11.4.3 Haosoh Glucagon-like Peptide-1 Receptor Agonist Introduction 11.4.4 Haosoh Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) 11.4.5 Haosoh Recent Development 11.5 Sanofi 11.5.1 Sanofi Company Details 11.5.2 Sanofi Business Overview 11.5.3 Sanofi Glucagon-like Peptide-1 Receptor Agonist Introduction 11.5.4 Sanofi Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) 11.5.5 Sanofi Recent Development 11.6 AstraZeneca 11.6.1 AstraZeneca Company Details 11.6.2 AstraZeneca Business Overview 11.6.3 AstraZeneca Glucagon-like Peptide-1 Receptor Agonist Introduction 11.6.4 AstraZeneca Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) 11.6.5 AstraZeneca Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Exenatide Table 3. Key Players of Liraglutide Table 4. Key Players of Lixisenatide Table 5. Key Players of Albiglutide Table 6. Key Players of Others Table 7. Global Glucagon-like Peptide-1 Receptor Agonist Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Glucagon-like Peptide-1 Receptor Agonist Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Glucagon-like Peptide-1 Receptor Agonist Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Regions (2016-2021) Table 11. Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Regions (2022-2027) Table 13. Glucagon-like Peptide-1 Receptor Agonist Market Trends Table 14. Glucagon-like Peptide-1 Receptor Agonist Market Drivers Table 15. Glucagon-like Peptide-1 Receptor Agonist Market Challenges Table 16. Glucagon-like Peptide-1 Receptor Agonist Market Restraints Table 17. Global Glucagon-like Peptide-1 Receptor Agonist Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Players (2016-2021) Table 19. Global Top Glucagon-like Peptide-1 Receptor Agonist Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon-like Peptide-1 Receptor Agonist as of 2020) Table 20. Ranking of Global Top Glucagon-like Peptide-1 Receptor Agonist Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Glucagon-like Peptide-1 Receptor Agonist Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Glucagon-like Peptide-1 Receptor Agonist Product Solution and Service Table 24. Date of Enter into Glucagon-like Peptide-1 Receptor Agonist Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) (US$ Million) Table 27. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Type (2016-2021) Table 28. Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Glucagon-like Peptide-1 Receptor Agonist Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Application (2016-2021) Table 32. Global Glucagon-like Peptide-1 Receptor Agonist Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) (US$ Million) Table 35. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) (US$ Million) Table 37. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size by Country (2022-2027) & (US$ Million) Table 64. GSK Company Details Table 65. GSK Business Overview Table 66. GSK Glucagon-like Peptide-1 Receptor Agonist Product Table 67. GSK Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) & (US$ Million) Table 68. GSK Recent Development Table 69. Novo Nordisk Company Details Table 70. Novo Nordisk Business Overview Table 71. Novo Nordisk Glucagon-like Peptide-1 Receptor Agonist Product Table 72. Novo Nordisk Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) & (US$ Million) Table 73. Novo Nordisk Recent Development Table 74. Lily Company Details Table 75. Lily Business Overview Table 76. Lily Glucagon-like Peptide-1 Receptor Agonist Product Table 77. Lily Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) & (US$ Million) Table 78. Lily Recent Development Table 79. Haosoh Company Details Table 80. Haosoh Business Overview Table 81. Haosoh Glucagon-like Peptide-1 Receptor Agonist Product Table 82. Haosoh Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) & (US$ Million) Table 83. Haosoh Recent Development Table 84. Sanofi Company Details Table 85. Sanofi Business Overview Table 86. Sanofi Glucagon-like Peptide-1 Receptor Agonist Product Table 87. Sanofi Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) & (US$ Million) Table 88. Sanofi Recent Development Table 89. AstraZeneca Company Details Table 90. AstraZeneca Business Overview Table 91. AstraZeneca Glucagon-like Peptide-1 Receptor Agonist Product Table 92. AstraZeneca Revenue in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) & (US$ Million) Table 93. AstraZeneca Recent Development Table 94. Research Programs/Design for This Report Table 95. Key Data Information from Secondary Sources Table 96. Key Data Information from Primary Sources List of Figures Figure 1. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Type: 2020 VS 2027 Figure 2. Exenatide Features Figure 3. Liraglutide Features Figure 4. Lixisenatide Features Figure 5. Albiglutide Features Figure 6. Others Features Figure 7. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Application: 2020 VS 2027 Figure 8. Solid Tumors Case Studies Figure 9. Blood-related Tumors Case Studies Figure 10. Glucagon-like Peptide-1 Receptor Agonist Report Years Considered Figure 11. Global Glucagon-like Peptide-1 Receptor Agonist Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Glucagon-like Peptide-1 Receptor Agonist Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Regions: 2020 VS 2027 Figure 14. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Regions (2022-2027) Figure 15. Global Glucagon-like Peptide-1 Receptor Agonist Market Share by Players in 2020 Figure 16. Global Top Glucagon-like Peptide-1 Receptor Agonist Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon-like Peptide-1 Receptor Agonist as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Glucagon-like Peptide-1 Receptor Agonist Revenue in 2020 Figure 18. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Type (2016-2021) Figure 19. Global Glucagon-like Peptide-1 Receptor Agonist Revenue Market Share by Type (2022-2027) Figure 20. North America Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2016-2027) Figure 22. North America Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2016-2027) Figure 23. North America Glucagon-like Peptide-1 Receptor Agonist Market Share by Country (2016-2027) Figure 24. United States Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2016-2027) Figure 28. Europe Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2016-2027) Figure 29. Europe Glucagon-like Peptide-1 Receptor Agonist Market Share by Country (2016-2027) Figure 30. Germany Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2016-2027) Figure 38. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2016-2027) Figure 39. Asia-Pacific Glucagon-like Peptide-1 Receptor Agonist Market Share by Region (2016-2027) Figure 40. China Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2016-2027) Figure 48. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2016-2027) Figure 49. Latin America Glucagon-like Peptide-1 Receptor Agonist Market Share by Country (2016-2027) Figure 50. Mexico Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Share by Type (2016-2027) Figure 54. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Share by Application (2016-2027) Figure 55. Middle East & Africa Glucagon-like Peptide-1 Receptor Agonist Market Share by Country (2016-2027) Figure 56. Turkey Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Glucagon-like Peptide-1 Receptor Agonist Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. GSK Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) Figure 60. Novo Nordisk Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) Figure 61. Lily Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) Figure 62. Haosoh Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) Figure 63. Sanofi Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) Figure 64. AstraZeneca Revenue Growth Rate in Glucagon-like Peptide-1 Receptor Agonist Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

GSK Novo Nordisk Lily Haosoh Sanofi AstraZeneca